These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35228659)

  • 1. Correction to: Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging.
    Gilman JM; Schmitt WA; Potter K; Kendzior B; Pachas GN; Hickey S; Makary M; Huestis MA; Evins AE
    Neuropsychopharmacology; 2022 May; 47(6):1282. PubMed ID: 35228659
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    Drug Metab Dispos; 1981; 9(3):261-4. PubMed ID: 6113937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EVALI Vaping Liquids Part 1: GC-MS Cannabinoids Profiles and Identification of Unnatural THC Isomers.
    Ciolino LA; Ranieri TL; Brueggemeyer JL; Taylor AM; Mohrhaus AS
    Front Chem; 2021; 9():746479. PubMed ID: 34631667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and determination of 11-oxo-delta8-tetrahydrocannabinol as an intermediate metabolite of delta8-tetrahydrocannabinol in the mouse brain and liver.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    J Pharmacobiodyn; 1980 Dec; 3(12):686-91. PubMed ID: 6268770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulating brain connectivity with δ⁹-tetrahydrocannabinol: a pharmacological resting state FMRI study.
    Klumpers LE; Cole DM; Khalili-Mahani N; Soeter RP; Te Beek ET; Rombouts SA; van Gerven JM
    Neuroimage; 2012 Nov; 63(3):1701-11. PubMed ID: 22885247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide.
    Hassenberg C; Clausen F; Hoffmann G; Studer A; Schürenkamp J
    Int J Legal Med; 2020 Nov; 134(6):2105-2119. PubMed ID: 32808050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the pharmacokinetics of 3H-delta9-tetrahydrocannabinol in mice by bacterial endotoxin.
    Martin BR; Montgomery J; Dewey WL; Harris LS
    Drug Metab Dispos; 1978; 6(3):282-7. PubMed ID: 26549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic mapping of the time-dependent effects of delta 9-tetrahydrocannabinol administration in the rat.
    Whitlow CT; Freedland CS; Porrino LJ
    Psychopharmacology (Berl); 2002 May; 161(2):129-36. PubMed ID: 11981592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
    Moody DE; Monti KM; Crouch DJ
    J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.
    Oishi R; Itoh Y; Nishibori M; Saeki K
    J Pharmacol Exp Ther; 1985 Feb; 232(2):513-8. PubMed ID: 2578567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
    Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
    Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of Delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic-mass spectrometric assay: assay validation and preliminary results of the "meconium project".
    Marchei E; Pellegrini M; Pacifici R; Palmi I; Lozano J; García-Algar O; Pichini S
    Ther Drug Monit; 2006 Oct; 28(5):700-6. PubMed ID: 17038890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublingual administration of Delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tervonen J; Jarho P
    Life Sci; 2006 Mar; 78(17):1911-4. PubMed ID: 16266727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure.
    Colizzi M; McGuire P; Giampietro V; Williams S; Brammer M; Bhattacharyya S
    Eur Neuropsychopharmacol; 2018 Jul; 28(7):850-862. PubMed ID: 29935939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo metabolism of the ethyl homologues of delta-8-tetrahydrocannabinol and delta-9-tetrahydrocannabinol in the mouse.
    Brown NK; Harvey DJ
    Biol Mass Spectrom; 1991 May; 20(5):324-8. PubMed ID: 1653028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
    Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
    Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
    Brenneisen R; Meyer P; Chtioui H; Saugy M; Kamber M
    Anal Bioanal Chem; 2010 Apr; 396(7):2493-502. PubMed ID: 20112012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol.
    Beardsley PM; Scimeca JA; Martin BR
    J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.